申请人:OTSUKA PHARMACEUTICAL CO., LTD.
公开号:US20210403456A1
公开(公告)日:2021-12-30
The present invention provides a novel heterocyclic compound represented by Formula [I] and a salt thereof:
wherein the symbols are as defined in the specification, which is useful for treating, preventing and/or diagnosing seizure and the like in disease involving epileptic seizure or convulsive seizure (including multiple drug resistant seizure, refractory seizure, acute symptomatic seizure, febrile seizure and status epilepticus), as well as a medical use therefor.